FY2026 Earnings Forecast for MRSH Issued By DOWLING & PARTN

Marsh & McLennan Companies, Inc. (NYSE:MRSHFree Report) – DOWLING & PARTN issued their FY2026 earnings per share estimates for Marsh & McLennan Companies in a research note issued on Wednesday, May 20th. DOWLING & PARTN analyst J. Christiana expects that the financial services provider will post earnings of $10.50 per share for the year. The consensus estimate for Marsh & McLennan Companies’ current full-year earnings is $10.37 per share. DOWLING & PARTN also issued estimates for Marsh & McLennan Companies’ FY2027 earnings at $11.50 EPS.

MRSH has been the subject of several other reports. Cantor Fitzgerald lifted their price target on Marsh & McLennan Companies from $208.00 to $212.00 and gave the company an “overweight” rating in a research report on Monday, February 2nd. Weiss Ratings cut Marsh & McLennan Companies from a “hold (c)” rating to a “hold (c-)” rating in a research report on Monday, May 11th. Morgan Stanley decreased their target price on Marsh & McLennan Companies from $195.00 to $190.00 and set an “equal weight” rating on the stock in a research report on Monday, April 6th. Mizuho decreased their target price on Marsh & McLennan Companies from $199.00 to $193.00 and set a “neutral” rating on the stock in a research report on Monday, April 13th. Finally, Barclays decreased their target price on Marsh & McLennan Companies from $209.00 to $206.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 8th. One analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, ten have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $203.56.

Read Our Latest Analysis on Marsh & McLennan Companies

Marsh & McLennan Companies Stock Up 0.1%

Shares of MRSH stock opened at $160.70 on Thursday. The stock has a 50 day moving average of $166.27 and a 200 day moving average of $172.72. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 1.28. The stock has a market cap of $77.63 billion, a P/E ratio of 20.09, a P/E/G ratio of 2.36 and a beta of 0.65. Marsh & McLennan Companies has a twelve month low of $158.16 and a twelve month high of $235.78.

Marsh & McLennan Companies (NYSE:MRSHGet Free Report) last announced its quarterly earnings results on Thursday, April 16th. The financial services provider reported $3.29 earnings per share for the quarter, beating the consensus estimate of $3.21 by $0.08. The company had revenue of $7.30 billion during the quarter. Marsh & McLennan Companies had a return on equity of 31.87% and a net margin of 14.26%.The company’s quarterly revenue was up 7.6% compared to the same quarter last year.

Institutional Trading of Marsh & McLennan Companies

Several large investors have recently added to or reduced their stakes in the stock. Numerai GP LLC increased its position in Marsh & McLennan Companies by 966.2% during the third quarter. Numerai GP LLC now owns 37,220 shares of the financial services provider’s stock worth $7,501,000 after buying an additional 33,729 shares during the period. Swiss Life Asset Management Ltd increased its position in Marsh & McLennan Companies by 9.5% during the fourth quarter. Swiss Life Asset Management Ltd now owns 134,542 shares of the financial services provider’s stock worth $24,960,000 after buying an additional 11,648 shares during the period. Rockland Trust Co. increased its position in Marsh & McLennan Companies by 801.6% during the third quarter. Rockland Trust Co. now owns 12,073 shares of the financial services provider’s stock worth $2,433,000 after buying an additional 10,734 shares during the period. Barclays PLC increased its position in Marsh & McLennan Companies by 41.7% during the third quarter. Barclays PLC now owns 2,202,372 shares of the financial services provider’s stock worth $443,844,000 after buying an additional 647,987 shares during the period. Finally, Bridges Investment Management Inc. increased its position in Marsh & McLennan Companies by 4.4% during the third quarter. Bridges Investment Management Inc. now owns 76,196 shares of the financial services provider’s stock worth $15,356,000 after buying an additional 3,177 shares during the period. 87.99% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Marsh & McLennan Companies

In other Marsh & McLennan Companies news, CEO John Q. Doyle sold 16,655 shares of the company’s stock in a transaction on Wednesday, March 4th. The stock was sold at an average price of $183.30, for a total value of $3,052,861.50. Following the completion of the sale, the chief executive officer directly owned 116,811 shares in the company, valued at $21,411,456.30. This represents a 12.48% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 0.38% of the stock is currently owned by insiders.

Marsh & McLennan Companies Company Profile

(Get Free Report)

Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.

Recommended Stories

Earnings History and Estimates for Marsh & McLennan Companies (NYSE:MRSH)

Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.